Antibiotics Market Size, Share & Industry Analysis, By Drug Class (Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, and Others), By Application (Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infection, Gastrointestinal Infections, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 3.1% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Drug Class

• Penicillin
• Cephalosporin
• Aminoglycosides
• Tetracycline
• Macrolides
• Fluoroquinolones
• Sulfonamides
• Others

By Application

• Skin Infections
• Respiratory Infections
• Urinary Tract Infections
• Septicemia
• Ear Infection
• Gastrointestinal Infections
• Others

By Route of Administration

• Oral
• Parenteral
• Others

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Geography

• North America (By Drug Class, Application, Route of Administration, Distribution Channel, and Country)
• U.S.
• Canada
• Europe (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
• U.K.
• Germany
• France
• Italy
• Spain
• Scandinavia
• Rest of Europe
• Asia-Pacific (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
• Japan
• China
• India
• Australia
• Southeast Asia
• Rest of Asia Pacific
• Latin America (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
• GCC
• South Africa
• Rest of the Middle East & Africa